Matt Scalo | Senior Vice President, Investor Relations |
Paul Diaz | President and Chief Executive Officer |
Bryan Riggsbee | Chief Financial Officer |
Nicole Lambert | Chief Operating Officer |
Mark Verratti | Chief Commercial Officer |
Matt Sykes | Goldman Sachs |
Andrew Cooper | Raymond James |
Jack Meehan | Nephron Research |
Greetings, and welcome to the Myriad Genetics Second Quarter 2023 Financial Earnings Call [Operator Instructions].
As a reminder, this conference is being recorded Thursday, August 3, 2023.
I'd now like to turn the call over to Matt Scalo, Senior Vice President, Investor Relations. Please go ahead, sir.
Thanks, Dave.